Events & Promotions
|
|
GMAT Club Daily Prep
Thank you for using the timer - this advanced tool can estimate your performance and suggest more practice questions. We have subscribed you to Daily Prep Questions via email.
Customized
for You
Track
Your Progress
Practice
Pays
Not interested in getting valuable practice questions and articles delivered to your email? No problem, unsubscribe here.
Sep 2807:00 PM EDT
-10:00 PM EDT
Boost your GMAT score in less than one month in a live online class + 6 months access to TTP OnDemand video courses included! Class starts Mon, Tues, Wed, Thur, Fri Sept. 28, 2026 - Oct. 16, 2027, 7:00pm-10:00pm EST
Sep 2911:00 AM EDT
-01:00 PM EDT
" Description: Top scores are possible when you enroll in a powerful GMAT course, taught live online + 6 months access to TTP OnDemand video courses included! Class starts Tues/Thur Sept. 29, 2026 - Dec. 3, 2026, 11:00am-1:00pm EST
Oct 0107:00 AM BST
-08:00 AM GMT
Welcome to the GMAT Club's Free Interview Prep Event for Top MBA Programs! Buy tickets - Virtual series that’s all set to equip you to -excel in your MBA interviews.
Oct 0301:00 PM EDT
-04:00 PM EDT
Top scores are possible when you enroll in a powerful GMAT course, taught live online + 6 months access to TTP OnDemand video courses included! Class starts Saturdays Oct. 3, 2026 - Dec. 26, 2026, 1:00pm-4:00pm EST
07 Feb 2025, 21:32
Kudos
Bookmarks
ᅠᅠA pharmaceutical company (hereafter, the company) developed Formula A, a prescription drug used to treat a common health condition. In the process of developing Formula A, the company also developed Formula B, a prescription drug derived from Formula A and used to treat the same condition.
ᅠᅠFor each prescription drug, the company was granted a 6-year exclusivity period'. a period of six years during which a company holds exclusive rights to produce and sell a drug that it has developed. The 6-year exclusivity period for Formula A spanned Years 1-6, while the 6-year exclusivity period for Formula B spanned Years 5-10.
ᅠᅠFor each prescription drug, the company was granted a 6-year exclusivity period'. a period of six years during which a company holds exclusive rights to produce and sell a drug that it has developed. The 6-year exclusivity period for Formula A spanned Years 1-6, while the 6-year exclusivity period for Formula B spanned Years 5-10.
Year 5
Be sure to select an answer first to save it in the Error Log before revealing the correct answer (OA)!
Difficulty:
5%
(low)
Question Stats:
88% (01:52) correct
12%
(01:40)
wrong
based on 1062
sessions
History
Date
Time
Result
Not Attempted Yet
Based on the information provided, in which one of the following years were the company's combined revenues from sales of Formulas A and B the least?
| Year 5 | |
| Year 6 | |
| Year 7 | |
| Year 8 | |
| Year 9 |
ShowHide Answer
Official Answer
Year 5
Predicted revenue from sales of Formulas B and C for Year 11 is less than total R&D expenditures for Year 10.: Sufficient information
Predicted total revenue for Year 11 is greater than total revenue for Year 10.: Insufficient information
Predicted total R&D expenditures for Year 11 are less than total R&D expenditures for Year 10.: Insufficient information
Be sure to select an answer first to save it in the Error Log before revealing the correct answer (OA)!
Difficulty:
75%
(hard)
Question Stats:
55% (01:56) correct
45%
(01:56)
wrong
based on 1293
sessions
History
Date
Time
Result
Not Attempted Yet
The company has been granted a 6-year exclusivity period, spanning Years 11-16, for Formula C, a new drug designed to treat a different condition than that treated by Formulas A and B. The company has made the following predictions for Year 11: revenue from sales of Formula B will be US$400 million, and revenue from sales of Formula C will be US$200 million.
For each of the following statements about the company, select Sufficient information if the given predictions and the information in the tabs provide sufficient information to determine that the statement is true. Otherwise, select Insufficient information.
For each of the following statements about the company, select Sufficient information if the given predictions and the information in the tabs provide sufficient information to determine that the statement is true. Otherwise, select Insufficient information.
| Sufficient information | Insufficient information | |
| Predicted revenue from sales of Formulas B and C for Year 11 is less than total R&D expenditures for Year 10. | ||
| Predicted total revenue for Year 11 is greater than total revenue for Year 10. | ||
| Predicted total R&D expenditures for Year 11 are less than total R&D expenditures for Year 10. |
ShowHide Answer
Official Answer
Predicted revenue from sales of Formulas B and C for Year 11 is less than total R&D expenditures for Year 10.: Sufficient information
Predicted total revenue for Year 11 is greater than total revenue for Year 10.: Insufficient information
Predicted total R&D expenditures for Year 11 are less than total R&D expenditures for Year 10.: Insufficient information
The company's total R&D expenditures were greater than those for any other year of the6-year exclusively period for Formula A.: No
The company's total R&D expenditures were greater than 10% of the company's total revenue.: No
Revenue from sales of Formula A accounted for more than 50% of the company's total revenue.: No
Be sure to select an answer first to save it in the Error Log before revealing the correct answer (OA)!
Difficulty:
85%
(hard)
Question Stats:
49% (02:02) correct
51%
(02:16)
wrong
based on 1338
sessions
History
Date
Time
Result
Not Attempted Yet
For each of the following statements about the final year of the 6-year exclusivity period for Formula A, select Yes if the statement is supported by the information in the tabs. Otherwise, select No.
| Yes | No | |
| The company's total R&D expenditures were greater than those for any other year of the6-year exclusively period for Formula A. | ||
| The company's total R&D expenditures were greater than 10% of the company's total revenue. | ||
| Revenue from sales of Formula A accounted for more than 50% of the company's total revenue. |
ShowHide Answer
Official Answer
The company's total R&D expenditures were greater than those for any other year of the6-year exclusively period for Formula A.: No
The company's total R&D expenditures were greater than 10% of the company's total revenue.: No
Revenue from sales of Formula A accounted for more than 50% of the company's total revenue.: No
Attachment:
2024-08-23_19-06-01.png [ 97.47 KiB | Viewed 11368 times ]
Attachment:
2024-08-23_19-03-17.png [ 101.23 KiB | Viewed 11397 times ]
Need more Tests to Practice?
GMAT Club Tests give expert solutions for every question in full and sectional GMAT Focus mocks.
Learn more →
25 Dec 2025, 03:04
Kudos
Bookmarks
2. The company has been granted a 6-year exclusivity period, spanning Years 11-16, for Formula C, a new drug designed to treat a different condition than that treated by Formulas A and B. The company has made the following predictions for Year 11: revenue from sales of Formula B will be US$400 million, and revenue from sales of Formula C will be US$200 million.
For each of the following statements about the company, select Sufficient information if the given predictions and the information in the tabs provide sufficient information to determine that the statement is true. Otherwise, select Insufficient information.
Using Year 11 predictions (B equals 400, C equals 200) plus the earlier tab information, we should decide whether we have enough information to conclude each statement is true.
• Predicted revenue from sales of Formulas B and C for Year 11 is less than total R and D expenditures for Year 10.
Predicted B plus C in Year 11 is 400 + 200 = 600. Year 10 total R and D is 800. Since 600 is less than 800, this is confirmed true.
Answer: Sufficient information
• Predicted total revenue for Year 11 is greater than total revenue for Year 10.
You are only told predicted sales revenue for B and C, not the company’s total revenue for Year 11. Total revenue could include other revenue sources (including anything besides B and C). So you cannot determine whether Year 11 total revenue exceeds Year 10 total revenue of 4000.
Answer: Insufficient information
• Predicted total R and D expenditures for Year 11 are less than total R and D expenditures for Year 10.
No prediction for Year 11 R and D spending is provided. So you cannot determine this.
Answer: Insufficient information
For each of the following statements about the company, select Sufficient information if the given predictions and the information in the tabs provide sufficient information to determine that the statement is true. Otherwise, select Insufficient information.
Using Year 11 predictions (B equals 400, C equals 200) plus the earlier tab information, we should decide whether we have enough information to conclude each statement is true.
• Predicted revenue from sales of Formulas B and C for Year 11 is less than total R and D expenditures for Year 10.
Predicted B plus C in Year 11 is 400 + 200 = 600. Year 10 total R and D is 800. Since 600 is less than 800, this is confirmed true.
Answer: Sufficient information
• Predicted total revenue for Year 11 is greater than total revenue for Year 10.
You are only told predicted sales revenue for B and C, not the company’s total revenue for Year 11. Total revenue could include other revenue sources (including anything besides B and C). So you cannot determine whether Year 11 total revenue exceeds Year 10 total revenue of 4000.
Answer: Insufficient information
• Predicted total R and D expenditures for Year 11 are less than total R and D expenditures for Year 10.
No prediction for Year 11 R and D spending is provided. So you cannot determine this.
Answer: Insufficient information
25 Dec 2025, 02:58
Kudos
Bookmarks
1. Based on the information provided, in which one of the following years were the company's combined revenues from sales of Formulas A and B the least?
Year 5: about 1400 from A plus about 200 from B equals about 1600
Year 6: 1000 from A plus 1000 from B equals 2000
Year 7: about 800 from A plus about 1600 from B equals about 2400
Year 8: about 100 from A plus about 1900 from B equals about 2000
Year 9: less than 10 from A plus about 2100 from B is a little over 2100
The least combined A plus B revenue is in Year 5.
GMAT-Club-Forum-pcbhfxgk.png [ 8.41 KiB | Viewed 2965 times ]
GMAT-Club-Forum-y8qvi0n6.png [ 75.13 KiB | Viewed 2963 times ]
Year 5: about 1400 from A plus about 200 from B equals about 1600
Year 6: 1000 from A plus 1000 from B equals 2000
Year 7: about 800 from A plus about 1600 from B equals about 2400
Year 8: about 100 from A plus about 1900 from B equals about 2000
Year 9: less than 10 from A plus about 2100 from B is a little over 2100
The least combined A plus B revenue is in Year 5.
Attachment:
GMAT-Club-Forum-pcbhfxgk.png [ 8.41 KiB | Viewed 2965 times ]
Attachment:
GMAT-Club-Forum-y8qvi0n6.png [ 75.13 KiB | Viewed 2963 times ]
